You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Monovalent vaccine

Showing 1 - 25 of 8,293
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Response To Dengue Exposure Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (rDENdelta30/31-7164)

Not yet recruiting
  • Response To Dengue Exposure
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 31, 2023

Ebola Sudan Virus Disease Trial in Siaya, Kampala (cAD3-Sudan Ebolavirus Vaccine, Placebo)

Not yet recruiting
  • Ebola Sudan Virus Disease
  • cAD3-Sudan Ebolavirus Vaccine
  • Placebo
  • Siaya, Kenya
  • +1 more
Sep 7, 2023

Marburg Virus Disease Trial in Siaya, Kampala (cAd3-Marburg vaccine, Placebo)

Not yet recruiting
  • Marburg Virus Disease
  • cAd3-Marburg vaccine
  • Placebo
  • Siaya, Kenya
  • +1 more
Apr 17, 2023

Hepatitis B, Vertical Transmission of Infectious Disease Trial in Kinshasa (Tenofovir Disoproxil Fumarate 300 MG, Hepatitis B

Not yet recruiting
  • Hepatitis B
  • Vertical Transmission of Infectious Disease
  • Tenofovir Disoproxil Fumarate 300 MG
  • +2 more
  • Kinshasa, Congo, The Democratic Republic of the
    Université Protestant au Congo
Jan 30, 2023

COVID-19 Trial in Manila, Putatan (SCB-2023 vaccine (trivalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for

Not yet recruiting
  • COVID-19
  • SCB-2023 vaccine (trivalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for COVID-19; intramuscular injection
  • SCB-2019 (monovalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for COVID-19; intramuscular injection
  • Manila, Philippines
  • +2 more
Jun 21, 2023

Influenza, Human Trial (FLU Q-PAN H5N8 Formulation 1, AS03B, AS03A)

Not yet recruiting
  • Influenza, Human
  • FLU Q-PAN H5N8 Formulation 1
  • +3 more
  • (no location specified)
Jul 27, 2023

Poliomyelitis Trial in United States (Novel Oral Polio Vaccine Type 1 (nOPV1), Novel Oral Polio Vaccine Type 3 (nOPV3), Sabin

Active, not recruiting
  • Poliomyelitis
  • Novel Oral Polio Vaccine Type 1 (nOPV1)
  • +3 more
  • Baltimore, Maryland
  • +3 more
Aug 24, 2022

Influenza Immunization Trial in Australia (H3 mRNA / LNP Vaccine, Quadrivalent recombinant influenza Vaccine (RIV4))

Recruiting
  • Influenza Immunization
  • H3 mRNA / LNP Vaccine
  • Quadrivalent recombinant influenza Vaccine (RIV4)
  • Herston, Queensland, Australia
  • +3 more
May 1, 2023

Covid19 Trial in Australia (SII B.1.351, SII Bivalent, SII B.1.617.2)

Withdrawn
  • Covid19
  • SII B.1.351
  • +2 more
  • Maroubra, New South Wales, Australia
  • +3 more
May 25, 2022

Influenza Vaccine Trial in United States (Cam2020 M2SR H3N2 influenza vaccine, Fluzone HD IIV, IN Placebo)

Completed
  • Influenza Vaccine
  • Cam2020 M2SR H3N2 influenza vaccine
  • +3 more
  • Port Orange, Florida
  • +5 more
Nov 11, 2022

Poliomyelitis Trial in Dhaka (Novel Live Attenuated Type 1 Oral Poliomyelitis Vaccine (nOPV1), Sabin Monovalent Oral

Not yet recruiting
  • Poliomyelitis
  • Novel Live Attenuated Type 1 Oral Poliomyelitis Vaccine (nOPV1)
  • Sabin Monovalent Oral Poliomyelitis Vaccine Type 1 (mOPV1)
  • Dhaka, Bangladesh
    International Centre for Diarrhoeal Disease Research, Bangladesh
Nov 30, 2022

Poliomyelitis Trial in Dhaka (Novel oral poliomyelitis vaccine type 1 (nOPV1), Novel oral poliomyelitis vaccine type 2 (nOPV2),

Not yet recruiting
  • Poliomyelitis
  • Novel oral poliomyelitis vaccine type 1 (nOPV1)
  • +3 more
  • Dhaka, Bangladesh
    International Centre for Diarrhoeal Disease Research
Nov 14, 2023

Influenza (Healthy Volunteers) Trial in Melbourne, Peoria (mRNA NA vaccine, High Dose Quadrivalent Influenza Vaccine)

Recruiting
  • Influenza (Healthy Volunteers)
  • mRNA NA vaccine
  • High Dose Quadrivalent Influenza Vaccine
  • Melbourne, Florida
  • +1 more
Jun 29, 2022

Poliomyelitis Trial in Panama City (Novel Live Attenuated Type 3 Oral Poliomyelitis Vaccine (nOPV3), Sabin Monovalent Oral

Not yet recruiting
  • Poliomyelitis
  • Novel Live Attenuated Type 3 Oral Poliomyelitis Vaccine (nOPV3)
  • Sabin Monovalent Oral Poliomyelitis Vaccine Type 3 (mOPV3)
  • Panama City, Panama
  • +3 more
Dec 14, 2022

Avian Influenza, H1N1 Influenza, Influenza Trial in Nashville (AS03, Influenza Virus Vaccine, Monovalent A/H3N2v

Completed
Has Results
  • Avian Influenza
  • +2 more
  • Nashville, Tennessee
    Vanderbilt University Medical Center - Vanderbilt Institute for
Jan 25, 2022

Influenza Vaccine Trial in Anaheim, DeLand, Lenexa (Sing2016 M2SR H3N2 influenza vaccine, Placebo)

Active, not recruiting
  • Influenza Vaccine
  • Sing2016 M2SR H3N2 influenza vaccine
  • Placebo
  • Anaheim, California
  • +2 more
May 13, 2022

Coronavirus Infection, COVID Trial in Adelaide (COVID19 vaccine, Saline)

Completed
  • Coronavirus Infection
  • COVID
  • COVID19 vaccine
  • Saline
  • Adelaide, South Australia, Australia
    PARC,
Feb 12, 2022

Shigella Trial in Baltimore (SF2a-TT15 Shigella Vaccine, Placebo, S. flexneri 2a strain 2457T Challenge Agent)

Recruiting
  • Shigella
  • SF2a-TT15 Shigella Vaccine
  • +2 more
  • Baltimore, Maryland
    University of Maryland, Baltimore, Center for Vaccine Developmen
May 5, 2022

Poliomyelitis Trial (Intradermal fractional dose inactivated polio vaccine (fIPV) in combination with recombinant double mutant

Recruiting
  • Poliomyelitis
  • Intradermal fractional dose inactivated polio vaccine (fIPV) in combination with recombinant double mutant heat labile toxin, LT(R192G/L211A), (dmLT)
  • +2 more
  • Burlington, Vermont
    University of Vermont Vaccine Testing Center at the Larner Colle
Sep 2, 2022

Influenza, Influenza Immunization Trial in United States (Influenza Hemagglutinin mRNA vaccine, Quadrivalent Recombinant

Completed
  • Influenza
  • Influenza Immunization
  • Influenza Hemagglutinin mRNA vaccine
  • Quadrivalent Recombinant Influenza Vaccine
  • Rolling Hills Estates, California
  • +19 more
Oct 31, 2023

Influenza, Influenza Vaccines Trial in Canada, Thailand, United States (Influenza A (H5N1) Virus monovalent vaccine, Saline )

Completed
Has Results
  • Influenza
  • Influenza Vaccines
  • Influenza A (H5N1) Virus monovalent vaccine
  • Saline placebo
  • Paramount, California
  • +16 more
Oct 19, 2021

Influenza, Human Trial in Gent, Wilrijk (GSK4382276A Dose level 1, GSK4382276A Dose level 2, GSK4382276A Dose level 3)

Active, not recruiting
  • Influenza, Human
  • GSK4382276A Dose level 1
  • +4 more
  • Edegem, Belgium
  • +6 more
Jan 9, 2023

Influenza A Trial in United States (LD Sing2016 M2SR H3N2 influenza vaccine, MD Sing2016 M2SR H3N2 influenza vaccine, HD

Completed
Has Results
  • Influenza A
  • LD Sing2016 M2SR H3N2 influenza vaccine
  • +4 more
  • Hollywood, Florida
  • +3 more
Dec 10, 2021

SARS-CoV-2 Trial (CV0701 Bivalent High dose, CV0701 Bivalent Medium dose, CV0701 Bivalent Low dose)

Not yet recruiting
  • SARS-CoV-2
  • CV0701 Bivalent High dose
  • +4 more
  • (no location specified)
Jul 24, 2023

COVID-19 Trial in Worldwide (SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 1, SARS-CoV-2 recombinant protein

Active, not recruiting
  • COVID-19
  • SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 1
  • +10 more
  • Birmingham, Alabama
  • +71 more
Jul 11, 2022